| | | SFA 12wk |
---|
| ↓ | |
---|
| LF 12wk | SFA 12wk | LF + At 2wk | SFA + At 2wk | LF + Pr 2wk | SFA + Pr 2wk | LF + Ib 2wk | SFA + Ib 2wk |
---|
Cholesterol (mM)
| 1.83 ± 0.20 | 1.54 ± 0.20 | 1.68 ± 0.11 | 1.69 ± 0.05 | 1.64 ± 0.13 | 1.91 ± 0.13 | 1.93 ± 0.12 | 1.59 ± 0.13 |
Triglycerides (mM)
| 0.74 ± 0.08 | 0.34 ± 0.04a | 0.39 ± 0.03a | 0.34 ± 0.02a | 0.36 ± 0.01a | 0.40 ± 0.04a | 0.42 ± 0.03a | 0.31 ± 0.02a |
NEFA (mEq/L)
| 0.85 ± 0.08 | 0.68 ± 0.04 | 0.93 ± 0.05 | 0.82 ± 0.04 | 1.02 ± 0.05b | 0.90 ± 0.08 | 1.05 ± 0.10b | 0.79 ± 0.05 |
- The table shows the effects of various feeding regimens on plasma lipids. Plasma total cholesterol, triglycerides and non-esterified fatty acids (NEFA) were measured at the end of the feeding regimen. Data represented as mean ± standard error of mean. Means were compared with non-parametric independent t test, where P < 0.05 considered statistically significant.
- a: statistically significant in comparison to LF;
- b: statistically significant in comparison to SFA.
- Abbreviations: LF, low-fat; SFA, saturated fatty acids; At, atorvastatin; Pr, pravastatin; Ib, ibuprofen; wk, weeks.